Safety and efficacy of low-dose ticagrelor in Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention

Safety and efficacy of low-dose ticagrelor in Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention

It remains unclear whether low-dose ticagrelor offers better safety and similar efficacy for Asian patients with acute coronary syndromes (ACS). We aimed to compare the safety and effectiveness of low-dose ticagrelor vs standard-dose ticagrelor in Chinese patients with ACS undergoing percutaneous co...

Full description

Bibliographic Details
Main Authors:	Yue Wang, Beibei Liu, Leilei Chen, Zhiqiang Wang, Xiaojiang Zhang, Min Suo, Gary S. Mintz, Xiaofan Wu
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-02-01
Series:	Platelets
Subjects:	low-dose ticagrelor acute coronary syndrome percutaneous coronary intervention safety
Online Access:	http://dx.doi.org/10.1080/09537104.2021.1909717

Similar Items

In-stent thrombosis when switching ticagrelor to clopidogrel after percutaneous coronary intervention
by: Aaron E. Brice, et al.
Published: (2017-04-01)

Efficacy and safety of switching from ticagrelor to clopidogrel during the early and late phase in acute coronary syndrome patients after percutaneous coronary intervention
by: Chenggang Wang, et al.
Published: (2020-04-01)

Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in Elderly Patients Undergoing Percutaneous Coronary Intervention: A Cohort Study
by: Meng S, et al.
Published: (2022-04-01)

Efficacy and safety of standard and low dose ticagrelor versus clopidogrel in east AsianPatients with chronic total occlusion undergoing percutaneous coronary intervention: a single center retrospective study
by: Yong Wang, et al.
Published: (2020-03-01)

Effect of Ticagrelor Compared to Clopidogrel on Short-term Outcomes of COVID-19 Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention; a Randomized Clinical Trial
by: Reza Arefizadeh, et al.
Published: (2023-01-01)

Comparison of clopidogrel and ticagrelor in treating acute coronary syndrome undergoing PCI: A systematic review and meta-analysis
by: Jing Yang, et al.
Published: (2024-03-01)

Comparisons between ticagrelor and clopidogrel following percutaneous coronary intervention in patients with acute coronary syndrome: a comprehensive meta-analysis
by: Fan ZG, et al.
Published: (2019-02-01)

Short-term clinical outcomes of ticagrelor versus clopidogrel after percutaneous coronary intervention in patients with myocardial infarction: A randomized clinical trial study
by: Salman Nikfarjam, et al.
Published: (2023-01-01)

Recovery of platelet reactivity following cessation of either aspirin or ticagrelor in patients treated with dual antiplatelet therapy following percutaneous coronary intervention: a GLOBAL LEADERS substudy
by: Barry W. Hennigan, et al.
Published: (2022-01-01)

Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor Versus Clopidogrel in Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Coronary Intervention
by: Joseph M. Sweeny, et al.
Published: (2017-04-01)

Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in Acute Coronary Syndrome: A Comprehensive Meta-Analysis
by: Mengyi Sun, et al.
Published: (2022-01-01)

Ticagrelor
by: Gianluca Airoldi, et al.
Published: (2013-03-01)

Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
by: Jialun Han, et al.
Published: (2023-03-01)

Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes ‐ A Post‐hoc Analysis of the ISAR‐REACT 5 Trial
by: Shqipdona Lahu, et al.
Published: (2022-12-01)

Choice of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention
by: A. N. Golosova, et al.
Published: (2020-08-01)

Modern Antiplatelet Therapy for Percutaneous Coronary Intervention. How to Make the Right Choice?
by: T. M. Uskach, et al.
Published: (2020-12-01)

Walking the Line with Ticagrelor: Meta-Analysis Comparing the Safety and Efficacy of Ticagrelor Monotherapy after a Short Course of Ticagrelor-Based Dual Antiplatelet Therapy versus Standard Therapy in Complex Percutaneous Coronary Intervention
by: Francesco Condello, et al.
Published: (2021-11-01)

Bivalirudin vs. heparin on a background of ticagrelor and aspirin in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A multicenter prospective cohort study
by: Xiao-Fan Yu, et al.
Published: (2022-10-01)

Sex-based outcomes on unguided de-escalation from ticagrelor to clopidogrel in stabilized patients with acute myocardial infarction undergoing percutaneous coronary intervention: a post-hoc analysis of the TALOS-AMI
by: Eun-Seok Shin, et al.
Published: (2024-03-01)

Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis
by: Janette Greenhalgh, et al.
Published: (2015-04-01)

TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement: The TIRATROP Study, A Randomized Controlled Trial
by: Thibault Lhermusier, et al.
Published: (2023-02-01)

Triglyceride-glucose index level and variability and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational cohort study
by: Yue Wang, et al.
Published: (2022-12-01)

Mind the Gap: Platelet Inhibition in Low‐Risk Acute Coronary Syndrome Undergoing Percutaneous Revascularization
by: Ravi K. Sharma, et al.
Published: (2019-12-01)

One-Month Outcomes of Cases Receiving Ticagrelor after Percutaneous Coronary Intervention; a Case Series
by: Mohammad Hasan Namazi, et al.
Published: (2020-04-01)

Ticagrelor monotherapy after a short course of dual antiplatelet therapy with ticagrelor plus aspirin following percutaneous coronary intervention in patients with versus without diabetes mellitus: a meta-analysis of randomized trials
by: Chen Ning, et al.
Published: (2024-03-01)

Effectiveness of “percutaneous coronary intervention care program” on selected variables among patients undergoing percutaneous coronary intervention
by: Poonam Sharma, et al.
Published: (2018-01-01)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
by: Ziwei Xi, et al.
Published: (2021-11-01)

IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)
by: Waseem Raja, et al.
Published: (2020-12-01)

Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
by: Wenbin Lu, et al.
Published: (2021-10-01)

Temporal Trends of Bleeding Episodes during Half- vs. Standard-Dose Ticagrelor in Acute Coronary Syndrome Patients with Low Platelet Reactivity: A Randomized BLEEDING-ACS Trial
by: Laeun Kim, et al.
Published: (2021-03-01)

Coronary Physiology: Modern Concepts for the Guidance of Percutaneous Coronary Interventions and Medical Therapy
by: Monica Verdoia, et al.
Published: (2023-03-01)

Early discontinuation of dual antiplatelet therapy via acetylsalicylic acid cessation in patients with acute coronary syndrome undergoing percutaneous coronary interventions to reduce the bleeding risk
by: O. V. Averkov
Published: (2021-02-01)

P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Po-Wei Chen, et al.
Published: (2020-06-01)

Efficacy and safety outcomes of ticagrelor compared with clopidogrel in Chinese elderly patients with acute coronary syndrome
by: Wang HD, et al.
Published: (2016-07-01)

In‐Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC‐ACS (Improving Care for Cardiovascular Disease in China‐Acute Coronary Syndrome) Project
by: Guanqi Zhao, et al.
Published: (2018-04-01)

Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis
by: Dong Wang, et al.
Published: (2018-11-01)

Pharmacodynamics and Outcomes of a De-Escalation Strategy with Half-Dose Prasugrel or Ticagrelor in East Asians Patients with Acute Coronary Syndrome: Results from HOPE-TAILOR Trial
by: Cai-De Jin, et al.
Published: (2021-06-01)

Clinical outcomes of patients undergoing percutaneous coronary intervention treated with colchicine
by: César E. Soria Jiménez, et al.
Published: (2023-05-01)

Quality of Life in Patients Undergoing Percutaneous Coronary Intervention
by: Vasiliki Tsoulou, et al.
Published: (2023-05-01)

Outcome of coronary angiography and percutaneous coronary intervention in Egyptian women with chronic stable angina
by: Mazen Tawfik, et al.
Published: (2011-03-01)